Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis

Nature Medicine

Volumn 15, Issue 4, 2009, Pages 417-424

  Binder, Nikolaus B ^a   Niederreiter, Birgit ^a   Hoffmann, Oskar ^a   Stange, Richard ^b   Pap, Thomas ^b   Stulnig, Thomas M ^a   MacK, Matthias ^c   Erben, Reinhold G ^d   Smolen, Josef S ^a   Redlich, Kurt ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CELL COUNT; CELL FUNCTION; CELL SIZE; CONTROLLED STUDY; FEMALE; HEALTH; HOMEOSTASIS; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STEM CELL; UPREGULATION; WILD TYPE;

ANIMALS; BONE AND BONES; BONE RESORPTION; ESTROGENS; FEMALE; MICE; MICE, KNOCKOUT; NF-KAPPA B; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PROTEIN KINASES; RECEPTORS, CCR2; TIBIA; UP-REGULATION;

MUS;

EID: 64449083350     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1945     Document Type: Article

References (44)

1. Teitelbaum, S.L. Bone resorption by osteoclasts. Science 289, 1504-1508 (2000).
2. Weitzmann, M.N. & Pacifici, R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest. 116, 1186-1194 (2006).
3. Miyamoto, T. & Suda, T. Differentiation and function of osteoclasts. Keio J. Med. 52, 1-7 (2003).
4. Stepan, J.J., Alenfeld, F., Boivin, G., Feyen, J.H. & Lakatos, P. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis. Endocr. Regul. 37, 225-238 (2003).
5. Tolar, J., Teitelbaum, S.L. & Orchard, P.J. Osteopetrosis. N. Engl. J. Med. 351, 2839-2849 (2004).
6. Choi, S.J. et al. Macrophage inflammatory protein 1-α is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96, 671-675 (2000).
7. Kim, M.S., Day, C.J. & Morrison, N.A. MCP-1 is induced by receptor activator of nuclear factor-κB ligand, promotes human osteoclast fusion and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J. Biol. Chem. 280, 16163-16169 (2005).
8. Kim, M.S. et al. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkB ligand for bone resorption. J. Biol. Chem. 281, 1274-1285 (2006).
9. Horuk, R. Chemokine receptors. Cytokine Growth Factor Rev. 12, 313-335 (2001).
10. Boring, L. et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100, 2552-2561 (1997).
11. Charo, I.F. et al. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxylterminal tails. Proc. Natl. Acad. Sci. USA 91, 2752-2756 (1994).
12. Jia, T. et al. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J. Immunol. 180, 6846-6853 (2008).
13. Kim, M.S., Magno, C.L., Day, C.J. & Morrison, N.A. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. J. Cell. Biochem. 97, 512-518 (2006).
14. Kruse, K. & Kracht, U. Evaluation of serum osteocalcin as an index of altered bone metabolism. Eur. J. Pediatr. 145, 27-33 (1986).
15. Russell, R.G. et al. Biochemical markers of bone turnover in Paget's disease. Metab. Bone Dis. Relat. Res. 3, 255-262 (1981).
16. Lacey, D.L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176 (1998).
17. Li, P. et al. Systemic tumor necrosis factor a mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor α-transgenic mice. Arthritis Rheum. 50, 265-276 (2004).
18. Tsou, CL. et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902-909 (2007).
19. Viedt, C. et al. Monocyte chemoattractant protein-1 induces proliferation and inter-leukin-6 production in human smooth muscle cells by differential activation of nuclear factor-κB and activator protein-1. Arterioscler. Thromb. Vasc. Biol. 22, 914-920 (2002).
20. Idris, A.I. et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat. Med. 11, 774-779 (2005).
21. Turner, R.T., Wakley, G.K., Hannon, K.S. & Bell, N.H. Tamoxifen inhibits osteoclastmediated resorption of trabecular bone in ovarian hormone-deficient rats. Endocrinology 122, 1146-1150 (1988).
22. Owen, J.L. et al. The expression of CCL2 byT lymphocytes of mammary tumor bearers: role of tumor-derived factors. Cell. Immunol. 235, 122-135 (2005).
23. Zallone, A. Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann. N.Y. Acad. Sci. 1068, 173-179 (2006).
24. Manolagas, S.C. & Jilka, R.L. Cytokines, hematopoiesis, osteoclastogenesis and estrogens. Calcif. Tissue Int. 50, 199-202 (1992).
25. Manolagas, S.C, Kousteni, S. & Jilka, R.L. Sex steroids and bone. Recent Prog. Horm. Res. 57, 385-409 (2002).
26. Manolagas, S.C. Role of cytokines in bone resorption. Bone 17, 63S-67S (1995).
27. Cenci, S. etal. Estrogen deficiency induces bone loss by enhancing T cell production of TNF-α. J. Clin. Invest. 106, 1229-1237 (2000).
28. Wei, S., Kitaura, H., Zhou, P., Ross, F.P. & Teitelbaum, S.L. IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 115, 282-290 (2005).
29. Lean, J.M., Murphy, C, Fuller, K. & Chambers, T.J. CCL9/MIP-1γ and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J. Cell. Biochem. 87, 386-393 (2002).
30. Breitkreutz, I. et al. Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma. Br. J. Haematol. 139, 55-63 (2007).
31. Janis, K. et al. Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes. Am. J. Reprod. Immunol. 51, 22-31 (2004).
32. Arici, A., Senturk, L.M., Seli, E., Bahtiyar, M.O. & Kim, G. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol. Reprod. 61, 85-90 (1999).
33. Koh, K.K. et al. Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels. Int. J. Cardiol. 81, 43-50 (2001).
34. McClung, M.R. et al. Denosumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 354, 821-831 (2006).
35. Dougall, W.C et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412-2424 (1999).
36. Kong, Y.Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323 (1999).
37. Yamada, Y, Ando, F, Niino, N. & Shimokata, H. Association of a polymorphism of the CC chemokine receptor-2 gene with bone mineral density. Genomics 80, 8-12 (2002).
38. Hayer, S. et al. CD44 is a determinant of inflammatory bone loss. J. Exp. Med. 201, 903-914 (2005).
39. Parfitt, A.M. et al. Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610 (1987).
40. Takeshita, S., Kaji, K. & Kudo, A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15, 1477-1488 (2000).
41. Takeshita, S. et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8, 943-949 (2002).
42. Herault, O. et al. A rapid single-laser flow cytometric method for discrimination of early apoptotic cells in a heterogenous cell population. Br. J. Haematol. 104, 530-537 (1999).
43. Redlich, K. et al. Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. Am. J. Pathol. 164, 543-555 (2004).
44. Mack, M. et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166, 4697-4704 (2001).